Search

Your search keyword '"Boyd, Brenna"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Boyd, Brenna" Remove constraint Author: "Boyd, Brenna"
72 results on '"Boyd, Brenna"'

Search Results

1. Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome (NODRS)

2. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

3. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

4. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

5. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

6. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

7. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

8. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

9. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

10. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

11. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

12. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

13. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

15. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

16. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

17. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

18. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

19. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

20. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

21. O35: Feasibility of expanded newborn screening using genome sequencing for early actionable conditions in a diverse city

22. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

23. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

25. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

27. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

28. Dual diagnosis of UQCRFS1-related mitochondrial complex III deficiency and recessive GJA8-related cataracts

30. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

31. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

32. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

33. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

34. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

35. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model

36. Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation.

37. Self-Reported Behavior Change and Predictors of Engagement With a Multidomain Brain Health Intervention for Midlife and Older Adults: A Pilot Clinical Trial.

38. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

39. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

40. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

42. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

44. Biallelic CRELD1variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

48. De novo variants in MRTFBhave gain-of-function activity in Drosophilaand are associated with a novel neurodevelopmental phenotype with dysmorphic features

Catalog

Books, media, physical & digital resources